- Corporate Officers - W
- Wicki Andreas
Insider Trading History of Wicki Andreas
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Wicki Andreas since 2011.
This trader's CIK number is 1511472.
At the time of last reporting, Wicki Andreas was the Officer of Harmony Biosciences Holdings, Inc.. (stock ticker symbol HRMY).
Also see all insider trading activities at Harmony Biosciences Holdings, Inc..
Note that in the past
Wicki Andreas also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Viela Bio, Inc. (VIE) by Wicki Andreas
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | VIE | 500,000 | $9,500,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Harmony Biosciences Holdings, Inc. (HRMY) by Wicki Andreas
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2022 | HRMY | 0 | $0 | 2,397,300 | $123,328,495 | 0 | $0 |
2021 | HRMY | 0 | $0 | 96,536 | $3,974,839 | 0 | $0 |
Yearly summary of insider trading at Pacira Biosciences, Inc. (PCRX) by Wicki Andreas
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2021 | PCRX | 0 | $0 | 241,546 | $17,460,674 | 0 | $0 |
2020 | PCRX | 0 | $0 | 257,392 | $15,740,253 | 0 | $0 |
2018 | PCRX | 0 | $0 | 149,738 | $7,317,359 | 0 | $0 |
2014 | PCRX | 0 | $0 | 592,094 | $52,904,745 | 0 | $0 |
2013 | PCRX | 0 | $0 | 1,820,832 | $53,148,044 | 0 | $0 |
2011 | PCRX | 843,406 | $5,749,996 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Wicki Andreas:
1. Viela Bio, Inc. (VIE)
2. Harmony Biosciences Holdings, Inc. (HRMY)
3. Pacira Biosciences, Inc. (PCRX)
Table 1. Insider trading of Viela Bio, Inc. (VIE) by Wicki Andreas
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-10-07 | VIE | Buy | 500,000 | 19.00 | 9,500,000 |
Table 2. Insider trading of Harmony Biosciences Holdings, Inc. (HRMY) by Wicki Andreas
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2022-12-12 | HRMY | Sale | 22,391 | 60.36 | 1,351,520 |
2022-12-13 | HRMY | Sale | 6,320 | 60.13 | 380,021 |
2022-12-14 | HRMY | Sale | 130 | 60.00 | 7,800 |
2022-12-05 | HRMY | Sale | 77,853 | 61.23 | 4,766,939 |
2022-11-15 | HRMY | Sale | 10,961 | 60.10 | 658,756 |
2022-11-14 | HRMY | Sale | 40,317 | 59.10 | 2,382,734 |
2022-11-08 | HRMY | Sale | 18,865 | 60.01 | 1,132,088 |
2022-11-10 | HRMY | Sale | 95,242 | 58.80 | 5,600,229 |
2022-11-09 | HRMY | Sale | 15,301 | 58.05 | 888,223 |
2022-11-03 | HRMY | Sale | 254,141 | 59.44 | 15,106,141 |
2022-11-02 | HRMY | Sale | 164,676 | 58.81 | 9,684,595 |
2022-11-04 | HRMY | Sale | 157,950 | 58.81 | 9,289,039 |
2022-08-09 | HRMY | Sale | 20,745 | 53.67 | 1,113,384 |
2022-08-08 | HRMY | Sale | 486,360 | 53.94 | 26,234,258 |
2022-08-10 | HRMY | Sale | 71,447 | 52.61 | 3,758,826 |
2022-08-03 | HRMY | Sale | 30,464 | 52.90 | 1,611,545 |
2022-08-04 | HRMY | Sale | 12,640 | 52.67 | 665,748 |
2022-08-05 | HRMY | Sale | 29,482 | 52.57 | 1,549,868 |
2022-03-11 | HRMY | Sale | 70,370 | 44.14 | 3,106,131 |
2022-03-10 | HRMY | Sale | 75,217 | 45.80 | 3,444,938 |
2022-03-09 | HRMY | Sale | 140,000 | 45.49 | 6,368,600 |
2022-03-02 | HRMY | Sale | 328,927 | 40.52 | 13,328,122 |
2022-03-03 | HRMY | Sale | 175,000 | 41.01 | 7,176,750 |
2022-03-01 | HRMY | Sale | 92,501 | 40.24 | 3,722,240 |
2021-12-10 | HRMY | Sale | 2,585 | 40.08 | 103,606 |
2021-12-08 | HRMY | Sale | 24,683 | 40.09 | 989,541 |
2021-11-17 | HRMY | Sale | 1,417 | 41.25 | 58,451 |
2021-11-16 | HRMY | Sale | 32,251 | 41.09 | 1,325,193 |
2021-11-15 | HRMY | Sale | 35,600 | 42.08 | 1,498,048 |
Table 3. Insider trading of Pacira Biosciences, Inc. (PCRX) by Wicki Andreas
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2021-03-12 | PCRX | Sale | 58,754 | 73.10 | 4,294,917 |
2021-03-15 | PCRX | Sale | 10,601 | 73.68 | 781,081 |
2021-03-09 | PCRX | Sale | 35,137 | 70.90 | 2,491,213 |
2021-03-10 | PCRX | Sale | 76,480 | 71.78 | 5,489,734 |
2021-03-11 | PCRX | Sale | 60,574 | 72.70 | 4,403,729 |
2020-09-09 | PCRX | Sale | 2,216 | 62.02 | 137,436 |
2020-08-13 | PCRX | Sale | 34,904 | 61.47 | 2,145,548 |
2020-08-12 | PCRX | Sale | 113,500 | 60.82 | 6,903,070 |
2020-08-11 | PCRX | Sale | 106,772 | 61.38 | 6,554,199 |
2018-12-12 | PCRX | Sale | 5,807 | 47.84 | 277,801 |
2018-12-13 | PCRX | Sale | 8,720 | 46.18 | 402,689 |
2018-11-19 | PCRX | Sale | 990 | 47.08 | 46,605 |
2018-11-15 | PCRX | Sale | 44,898 | 47.64 | 2,138,850 |
2018-11-16 | PCRX | Sale | 25,600 | 46.93 | 1,201,356 |
2018-11-12 | PCRX | Sale | 5,478 | 49.83 | 272,979 |
2018-11-08 | PCRX | Sale | 57,339 | 51.13 | 2,931,571 |
2018-11-09 | PCRX | Sale | 906 | 50.23 | 45,508 |
2014-08-28 | PCRX | Sale | 11,013 | 108.06 | 1,190,097 |
2014-08-29 | PCRX | Sale | 10,481 | 108.15 | 1,133,562 |
2014-08-25 | PCRX | Sale | 30,000 | 108.07 | 3,241,980 |
2014-08-26 | PCRX | Sale | 24,207 | 108.11 | 2,617,018 |
2014-08-27 | PCRX | Sale | 1,606 | 108.05 | 173,534 |
2014-08-08 | PCRX | Sale | 82,100 | 101.00 | 8,292,100 |
2014-08-11 | PCRX | Sale | 67,900 | 101.51 | 6,892,529 |
2014-06-09 | PCRX | Sale | 68,000 | 85.60 | 5,820,596 |
2014-06-04 | PCRX | Sale | 4,500 | 82.40 | 370,809 |
2014-06-05 | PCRX | Sale | 23,200 | 82.53 | 1,914,672 |
2014-06-06 | PCRX | Sale | 40,200 | 82.70 | 3,324,741 |
2014-06-03 | PCRX | Sale | 57,400 | 80.72 | 4,633,213 |
2014-06-02 | PCRX | Sale | 10,600 | 80.52 | 853,501 |
2014-05-27 | PCRX | Sale | 64,400 | 77.93 | 5,018,756 |
2014-05-21 | PCRX | Sale | 3,600 | 77.80 | 280,087 |
2014-05-08 | PCRX | Sale | 23,220 | 75.76 | 1,759,216 |
2014-05-07 | PCRX | Sale | 600 | 75.64 | 45,385 |
2014-05-06 | PCRX | Sale | 44,180 | 75.78 | 3,348,048 |
2014-03-05 | PCRX | Sale | 22,687 | 80.16 | 1,818,657 |
2014-03-06 | PCRX | Sale | 2,200 | 80.11 | 176,244 |
2013-09-11 | PCRX | Sale | 17,783 | 37.25 | 662,416 |
2013-07-19 | PCRX | Sale | 56,020 | 34.98 | 1,959,523 |
2013-07-22 | PCRX | Sale | 19,938 | 35.28 | 703,512 |
2013-07-18 | PCRX | Sale | 4,042 | 34.80 | 140,661 |
2013-07-17 | PCRX | Sale | 21,518 | 33.20 | 714,397 |
2013-07-15 | PCRX | Sale | 48,132 | 33.28 | 1,601,832 |
2013-07-16 | PCRX | Sale | 350 | 33.20 | 11,620 |
2013-07-11 | PCRX | Sale | 80,000 | 31.48 | 2,518,400 |
2013-07-05 | PCRX | Sale | 44,021 | 30.80 | 1,355,978 |
2013-07-02 | PCRX | Sale | 60,597 | 29.85 | 1,808,820 |
2013-07-03 | PCRX | Sale | 50,000 | 30.67 | 1,533,300 |
2013-07-01 | PCRX | Sale | 3,851 | 29.85 | 114,952 |
2013-06-19 | PCRX | Sale | 35,407 | 29.90 | 1,058,740 |
2013-06-17 | PCRX | Sale | 50,145 | 29.86 | 1,497,229 |
2013-06-12 | PCRX | Sale | 4,409 | 30.00 | 132,270 |
2013-06-11 | PCRX | Sale | 9,000 | 30.00 | 270,000 |
2013-06-10 | PCRX | Sale | 2,500 | 30.00 | 75,000 |
2013-06-04 | PCRX | Sale | 13,000 | 30.31 | 394,030 |
2013-06-05 | PCRX | Sale | 2,500 | 30.00 | 75,000 |
2013-06-03 | PCRX | Sale | 1,900 | 30.00 | 57,000 |
2013-05-31 | PCRX | Sale | 3,033 | 30.00 | 90,990 |
2013-05-30 | PCRX | Sale | 2,500 | 30.00 | 75,000 |
2013-05-22 | PCRX | Sale | 18,471 | 30.00 | 554,130 |
2013-05-20 | PCRX | Sale | 14,374 | 30.00 | 431,220 |
2013-04-24 | PCRX | Sale | 401 | 30.04 | 12,044 |
2013-04-23 | PCRX | Sale | 15,646 | 30.00 | 469,380 |
2013-04-15 | PCRX | Sale | 6,400 | 30.00 | 192,019 |
2013-04-11 | PCRX | Sale | 600 | 30.00 | 18,000 |
2013-04-12 | PCRX | Sale | 34,294 | 30.00 | 1,028,820 |
2013-03-25 | PCRX | Sale | 165,541 | 28.27 | 4,680,671 |
2013-03-21 | PCRX | Sale | 11,431 | 27.50 | 314,352 |
2013-03-22 | PCRX | Sale | 113,928 | 27.52 | 3,135,640 |
2013-03-18 | PCRX | Sale | 400,000 | 28.19 | 11,277,600 |
2013-03-19 | PCRX | Sale | 9,100 | 27.86 | 253,498 |
2013-03-11 | PCRX | Sale | 500,000 | 27.86 | 13,930,000 |
2011-11-21 | PCRX | Buy | 307,692 | 6.50 | 1,999,998 |
2011-02-08 | PCRX | Buy | 535,714 | 7.00 | 3,749,998 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Wicki Andreas
(Officer of Harmony Biosciences Holdings, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.